Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,690 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 637
Recruiting: 366
Ph III recruiting: 20
Growth YoY: −13.8%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 1,851–1,900 of 2,690 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00767819	Treatment of Patients With RAD001 With Progressive Sarcoma	completed	Phase 2	71	Novartis PharmaceuticalsINDUSTRY	2	Apr 1, 2019	clinicaltrials
NCT03029481	Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma	no longer available	—	—	Jonsson Comprehensive Cancer CenterOTHER	0	Mar 28, 2019	clinicaltrials